Kebomed UK Ltd. 05453655 false 2025-07-01 2026-06-30 2026-06-30 The principal activity of the company is that of distributing medical and surgical equipment Digita Accounts Production Advanced 6.30.9574.0 true false 05453655 2025-07-01 2026-06-30 05453655 2026-06-30 05453655 core:RetainedEarningsAccumulatedLosses 2026-06-30 05453655 core:ShareCapital 2026-06-30 05453655 core:CurrentFinancialInstruments core:WithinOneYear 2026-06-30 05453655 core:FurnitureFittingsToolsEquipment 2026-06-30 05453655 core:PlantMachinery 2026-06-30 05453655 bus:SmallEntities 2025-07-01 2026-06-30 05453655 bus:Audited 2025-07-01 2026-06-30 05453655 bus:FullAccounts 2025-07-01 2026-06-30 05453655 bus:SmallCompaniesRegimeForAccounts 2025-07-01 2026-06-30 05453655 bus:RegisteredOffice 2025-07-01 2026-06-30 05453655 bus:CompanySecretaryDirector2 2025-07-01 2026-06-30 05453655 bus:PrivateLimitedCompanyLtd 2025-07-01 2026-06-30 05453655 core:FurnitureFittings 2025-07-01 2026-06-30 05453655 core:FurnitureFittingsToolsEquipment 2025-07-01 2026-06-30 05453655 core:PlantMachinery 2025-07-01 2026-06-30 05453655 1 2025-07-01 2026-06-30 05453655 countries:EnglandWales 2025-07-01 2026-06-30 05453655 2025-06-30 05453655 core:FurnitureFittingsToolsEquipment 2025-06-30 05453655 core:PlantMachinery 2025-06-30 05453655 2024-07-01 2025-06-30 05453655 2025-06-30 05453655 core:RetainedEarningsAccumulatedLosses 2025-06-30 05453655 core:ShareCapital 2025-06-30 05453655 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 05453655 core:FurnitureFittingsToolsEquipment 2025-06-30 05453655 core:PlantMachinery 2025-06-30 iso4217:GBP xbrli:pure

Company registration number: 05453655

Kebomed UK Ltd.

Filleted Annual Report and Financial Statements

for the Year Ended 30 June 2026

 

Kebomed UK Ltd.

Contents

Balance Sheet

1

Notes to the Financial Statements

2 to 6

 

Kebomed UK Ltd.

(Registration number: 05453655)
Balance Sheet as at 30 June 2026

Note

2026
£

2025
£

Fixed assets

 

Tangible assets

4

55,451

41,225

Current assets

 

Stocks

5

4,064,410

3,416,857

Debtors

6

3,145,152

3,750,340

Cash at bank and in hand

 

1,851,810

1,946,664

 

9,061,372

9,113,861

Creditors: Amounts falling due within one year

7

(7,375,077)

(6,237,954)

Net current assets

 

1,686,295

2,875,907

Total assets less current liabilities

 

1,741,746

2,917,132

Provisions for liabilities

 

Deferred tax liabilities

 

(10,306)

(10,306)

Net assets

 

1,731,440

2,906,826

Capital and reserves

 

Called up share capital

65,000

65,000

Profit and loss account

1,666,440

2,841,826

Total equity

 

1,731,440

2,906,826

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 20 October 2026 and signed on its behalf by:
 


G C Laws
Company secretary and director

   
 

Kebomed UK Ltd.

Notes to the Financial Statements
for the Year Ended 30 June 2026

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Swaines Hill Manor
South Warnborough
Alton
Hampshire
GU34 4DP

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

These financial statements are presented in Sterling (£).

Judgements

The directors have concluded that the going concern basis is appropriate for the preparation of these accounts. This takes account of the profitability of the company, the cash resources available to the company and the ongoing support of the parent company.

Turnover recognition

Turnover represents amounts chargeable, net of value added tax, in respect of the sale of goods and services to customers. Turnover is recognised when goods are despatched.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

 

Kebomed UK Ltd.

Notes to the Financial Statements
for the Year Ended 30 June 2026

Tax

Tax is recognised in the profit and loss account, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on timing differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reivewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Deferred tax liabilities are presented within provisions for liabilities on the balance sheet.

Tangible assets

Tangible assets are stated at cost, less accumulated depreciation and accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation of tangible assets

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and equipment

33% straight line

Plant and machinery

20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Kebomed UK Ltd.

Notes to the Financial Statements
for the Year Ended 30 June 2026

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Intercompany balances

The company has balances with other members of the wider group. These are initially measured at transaction price and any debtor balances are subsequently reviewed for impairment.

Interest is charged on balances older than 60 days, this is recognised in the profit and loss account.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in the profit and loss account when they fall due. Amounts not paid are shown in accruals as a liability in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.

 

Kebomed UK Ltd.

Notes to the Financial Statements
for the Year Ended 30 June 2026

3

Staff numbers

The average number of persons employed by the company (including directors) during the year was 28 (2025 - 23).

4

Tangible assets

Furniture, fittings and equipment
 £

Plant and machinery
 £

Total
£

Cost or valuation

At 1 July 2025

42,553

18,400

60,953

Additions

34,001

-

34,001

At 30 June 2026

76,554

18,400

94,954

Depreciation

At 1 July 2025

17,275

2,453

19,728

Charge for the year

16,095

3,680

19,775

At 30 June 2026

33,370

6,133

39,503

Carrying amount

At 30 June 2026

43,184

12,267

55,451

At 30 June 2025

25,278

15,947

41,225

5

Stocks

2026
£

2025
£

Finished goods and goods for resale

4,064,410

3,416,857

6

Debtors

Current

2026
£

2025
£

Trade debtors

2,951,528

3,577,004

Prepayments

41,780

21,694

Other debtors

469

-

Amounts owed by group undertakings

151,375

151,642

 

3,145,152

3,750,340

 

Kebomed UK Ltd.

Notes to the Financial Statements
for the Year Ended 30 June 2026

7

Creditors

Creditors: amounts falling due within one year

2026
£

2025
£

Trade creditors

6,537,559

5,102,486

Taxation and social security

699,511

1,001,881

Accruals and deferred income

137,268

133,587

Other creditors

739

-

7,375,077

6,237,954

8

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £810,450 (2025 - £561,240) in relation to rent and $14,946,371 (2025 - $19,235,330) in relation to stock purchases from a supplier in the period from the balance sheet date to 31 December 2028. The increase in commitments in relation to rent compared to the prior year is due to an amendment in rent with effect from 1 July 2025.

9

Parent and ultimate parent undertaking

The company's immediate parent is Kebomed Europe Holding AG, incorporated in Switzerland.

10

Audit Report

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 21 October 2026 was Robert Oram BFP FCA, who signed for and on behalf of Albert Goodman LLP.